WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Recovery Control Tower Feasibility Pilot

Not Applicable

Recruiting

Conditions: Elective Surgery

First Posted Date: 2024-12-13

Last Posted Date: 2024-12-13

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 8500

Registration Number: NCT06732921

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

A Pragmatic Trial on Actions for Collaborative Community Engaged Strategies for HPV

Not Applicable

Not yet recruiting

Conditions: HPV

First Posted Date: 2024-12-11

Last Posted Date: 2024-12-18

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1224

Registration Number: NCT06728085

Locations: 🇳🇬
Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria

Light Therapy for Obsessive-compulsive Disorder (OCD)

Early Phase 1

Recruiting

Conditions: OCD

First Posted Date: 2024-12-06

Last Posted Date: 2024-12-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 40

Registration Number: NCT06720090

Locations: 🇺🇸
Washington University, St. Louis, Missouri, United States

mHealth to Help Pregnant and Postpartum Women in Recovery for Opioid Use Disorder

Early Phase 1

Completed

Conditions: Opioid Use Disorders

First Posted Date: 2024-11-22

Last Posted Date: 2024-11-22

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 69

Registration Number: NCT06701123

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

The Minimalist Trial-2

Phase 2

Not yet recruiting

Conditions: HPV-Related Oropharynx Squamous Cell Carcinoma

Interventions: Radiation: Radiation therapy
Drug: Cisplatin
Procedure: Surgery

First Posted Date: 2024-11-22

Last Posted Date: 2024-11-22

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 153

Registration Number: NCT06702033

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant

Phase 2

Not yet recruiting

Conditions: Diffuse Large B Cell Lymphoma

Interventions: Drug: Thiotepa
Drug: Carmustine
Procedure: Autologous Stem Cell Transplant
Drug: Anthracycline-based induction chemotherapy

First Posted Date: 2024-11-14

Last Posted Date: 2024-11-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 36

Registration Number: NCT06687772

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy

Not Applicable

Recruiting

Conditions: Hematologic Malignancy
Solid Tumor
Sickle Cell Disease
Aplastic Anemia
Immune Deficiency
Metabolic Disorder

First Posted Date: 2024-11-14

Last Posted Date: 2024-11-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 60

Registration Number: NCT06689800

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Phase 1

Not yet recruiting

Conditions: Metastatic Pancreatic Ductal Adenocarcinoma
Pancreatic Cancer
Cancer of the Pancreas

Interventions: Drug: Zunsemetinib
Drug: mFOLFIRINOX

First Posted Date: 2024-10-18

Last Posted Date: 2024-10-18

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 51

Registration Number: NCT06648434

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Phase 2

Recruiting

Conditions: Alzheimers Disease
Dementia
Alzheimers Disease, Familial

Interventions: Drug: Remternetug
Drug: Matching Placebo (Remternetug)

First Posted Date: 2024-10-17

Last Posted Date: 2024-11-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 280

Registration Number: NCT06647498

Locations: 🇺🇸
University of Alabama in Birmingham, Birmingham, Alabama, United States
🇺🇸
University of California San Diego Medical Center, La Jolla, California, United States
🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

and more 32 locations

Promotion of RSV Immunization Through Multiple Efforts

Phase 3

Not yet recruiting

Conditions: Pregnancy
Vaccination

First Posted Date: 2024-10-14

Last Posted Date: 2024-10-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 50

Registration Number: NCT06640868

Locations: 🇺🇸
Washington University in St. Louis, St Louis, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy